Altimmune Inc. (NASDAQ: ALT) reported that its investigational drug pemvidutide demonstrated reductions in triglycerides and cholesterol levels in patients with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE